摘要:
This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.
摘要:
Novel compounds having structure (1), wherein Z, Y, R1, R2' and R2 are defined in the specification, are provided for use in the treatment of tumors and the prophylaxis or treatment of viral infections.
摘要:
A motor assembly comprises a first end frame, a second end frame including at least one air outlet aperture, an air shroud surrounding a stator between the first end frame and the second end frame, the air shroud cooperating with the stator to form at least one air passage, and cooperating with the first end frame to form at least one air inlet aperture. The motor assembly also comprises a fan mounted on the rotating shaft, the fan operable to generate an air flow of ambient air through the at least one air inlet aperture, the at least one air passage and the at least one air outlet aperture. The motor assembly further comprises a housing coupled to the air shroud and defining an inner space containing an electronic module operable to control the motor assembly, the housing including a cap operable to permanently seal the inner space. Finally there is provided a thermostat in thermal relationship with the at least one portion of the set of windings.
摘要:
Provided are compounds of Formula I: (I) and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
摘要:
The invention is related to phosphorus substituted anti-infective compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
摘要:
This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.
摘要:
Pyrido(3,2-d)pyrimidine derivatives represented by the structural formuia (Ia): wherein, R 1 , R 2 and R 3 are defined herein, pharmaceutical acceptable addition salts, stereochemical isomeric forms, N -oxides, solvates and pro-drugs thereof, for use in the treatment of hepatitis C.
摘要:
The invention is related to phosphorus substituted kinase inhibitory conjugates, compositions containing such conjugates, and therapeutic methods that include the administration of such conjugates, as well as to processes and intermediates useful for preparing such conjugates.
摘要:
A compound of formula (1), and/or its salts, tautomers or solvates is used to treat hematological malignancies. In an embodiment, an organic acid salt of compound 1 is provided for general use in treatment of neoplasms, and in a further embodiment the salt is stabilized with carbohydrate.
摘要:
Phosphorus substituted mycophenolate oxime derivatives with anti-cancer, anti-viral, anti-inflammatory and anti-tissue/organ transplant rejection properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit tumor growth, viral growth, inflammation, and tissue/organ transplant rejection and/or are useful therapeutically for the treatment or prevention of cancer, viral infection, inflammation and tissue/organ transplant rejection, as well as in assays for the detection of cancer, viral infection, inflammation and tissue/organ transplant rejection.